DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $3,782 | $4,625 | $4,559 | $3,917 |
| - Cash | $134 | $508 | $269 | $595 |
| + Debt | $5,328 | $5,678 | $6,050 | $7,283 |
| Enterprise Value | $8,975 | $9,795 | $10,340 | $10,605 |
| Revenue | $228 | $477 | $701 | $526 |
| % Growth | -52.3% | -32% | 33.4% | – |
| Gross Profit | -$7 | $86 | $186 | $181 |
| % Margin | -2.9% | 18% | 26.6% | 34.4% |
| EBITDA | -$1,507 | -$1,277 | -$1,014 | -$1,296 |
| % Margin | -662.2% | -267.8% | -144.7% | -246.6% |
| Net Income | -$1,881 | -$1,697 | $2,888 | -$3,861 |
| % Margin | -826.7% | -355.8% | 412% | -734.5% |
| EPS Diluted | -0.003 | -0.003 | 0.01 | -0.009 |
| % Growth | 0% | -130% | 211.1% | – |
| Operating Cash Flow | -$1,362 | -$1,208 | -$1,247 | -$324 |
| Capital Expenditures | -$2 | $0 | -$2 | -$161 |
| Free Cash Flow | -$1,363 | -$1,208 | -$1,249 | -$486 |